Laetitia Fend

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli et al. · Nature Medicine · 2014 · 1K citations

Medicine, Cancer Biology, Oncology +12

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

Laetitia Fend, Takahiro Yamazaki, Christelle Remy et al. · Cancer Research · 2017 · 126 citations

Medicine, Immunology, Oncology +17

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition

Patricia Kleinpeter, Laetitia Fend, Christine Thioudellet et al. · OncoImmunology · 2016 · 95 citations · Full text

Medicine, Cancer Biology, Oncology +17

Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts

Laetitia Fend, Nathalie Accart, Jacqueline Kintz et al. · PLoS ONE · 2013 · 60 citations · Full text

Medicine, Immunology, Oncology +16

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer

Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll et al. · OncoImmunology · 2017 · 42 citations · Full text

Life Sciences, Immunology, Oncology +17